SEC Comment Letter 0000000000-23-005409 to Aravive, Inc. (CIK 0001513818)
Aravive, Inc. (CIK 0001513818)
Date: May 22, 2023 · CIK: 0001513818 · Accession: 0000000000-23-005409
AI Filing Summary & Sentiment
File numbers found in text: 001-36361
Letter
United States securities and exchange commission logo May 22, 2023 Rudy C. Howard Chief Financial Officer Aravive, Inc. River Oaks Tower 3730 Kirby Drive, Suite 1200 Houston , Texas 77098 Re:Aravive, Inc. Form 10-K for Fiscal Year Ended December 31, 2022 Filed March 15, 2023 File No. 001-36361 Dear Rudy C. Howard: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
May 22, 2023
Rudy C. Howard
Chief Financial Officer
Aravive, Inc.
River Oaks Tower
3730 Kirby Drive, Suite 1200
Houston , Texas 77098
Re:Aravive, Inc.
Form 10-K for Fiscal Year Ended December 31, 2022
Filed March 15, 2023
File No. 001-36361
Dear Rudy C. Howard:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences